238 related articles for article (PubMed ID: 12325162)
1. Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides.
Bowman MJ; Chmielewski J
Biopolymers; 2002; 66(2):126-33. PubMed ID: 12325162
[TBL] [Abstract][Full Text] [Related]
2. Sidechain-linked inhibitors of HIV-1 protease dimerization.
Bowman MJ; Chmielewski J
Bioorg Med Chem; 2009 Feb; 17(3):967-76. PubMed ID: 18337105
[TBL] [Abstract][Full Text] [Related]
3. Development of low molecular weight HIV-1 protease dimerization inhibitors.
Hwang YS; Chmielewski J
J Med Chem; 2005 Mar; 48(6):2239-42. PubMed ID: 15771466
[TBL] [Abstract][Full Text] [Related]
4. Dimerization inhibitors of HIV-1 protease.
Boggetto N; Reboud-Ravaux M
Biol Chem; 2002 Sep; 383(9):1321-4. PubMed ID: 12437124
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of HIV-1 protease by interface peptides.
Schramm HJ; Billich A; Jaeger E; Rücknagel KP; Arnold G; Schramm W
Biochem Biophys Res Commun; 1993 Jul; 194(2):595-600. PubMed ID: 8343146
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.
Shultz MD; Ham YW; Lee SG; Davis DA; Brown C; Chmielewski J
J Am Chem Soc; 2004 Aug; 126(32):9886-7. PubMed ID: 15303839
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E
Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209
[TBL] [Abstract][Full Text] [Related]
8. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
Quéré L; Wenger T; Schramm HJ
Biochem Biophys Res Commun; 1996 Oct; 227(2):484-8. PubMed ID: 8967903
[TBL] [Abstract][Full Text] [Related]
9. A folding inhibitor of the HIV-1 protease.
Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G
Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559
[TBL] [Abstract][Full Text] [Related]
10. A unidirectional crosslinking strategy for HIV-1 protease dimerization inhibitors.
Hwang YS; Chmielewski J
Bioorg Med Chem Lett; 2004 Aug; 14(16):4297-300. PubMed ID: 15261290
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization.
Bouras A; Boggetto N; Benatalah Z; de Rosny E; Sicsic S; Reboud-Ravaux M
J Med Chem; 1999 Mar; 42(6):957-62. PubMed ID: 10090778
[TBL] [Abstract][Full Text] [Related]
12. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
[TBL] [Abstract][Full Text] [Related]
13. An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface.
Bannwarth L; Reboud-Ravaux M
Biochem Soc Trans; 2007 Jun; 35(Pt 3):551-4. PubMed ID: 17511649
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on inhibitors of HIV protease: a target for drug design.
Jayaraman S; Shah K
In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease.
Sperka T; Pitlik J; Bagossi P; Tözsér J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3086-90. PubMed ID: 15893929
[TBL] [Abstract][Full Text] [Related]
16. Oximinoarylsulfonamides as potent HIV protease inhibitors.
Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ
Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308
[TBL] [Abstract][Full Text] [Related]
17. Switching between allosteric and dimerization inhibition of HIV-1 protease.
Bowman MJ; Byrne S; Chmielewski J
Chem Biol; 2005 Apr; 12(4):439-44. PubMed ID: 15850980
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 protease folding and the design of drugs which do not create resistance.
Broglia R; Levy Y; Tiana G
Curr Opin Struct Biol; 2008 Feb; 18(1):60-6. PubMed ID: 18160276
[TBL] [Abstract][Full Text] [Related]
19. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
Frecer V; Berti F; Benedetti F; Miertus S
J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
[TBL] [Abstract][Full Text] [Related]
20. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem.
Dunn BM; Pennington MW; Frase DC; Nash K
Biopolymers; 1999; 51(1):69-77. PubMed ID: 10380354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
